A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics
Translating preclinical safety findings into reliable insights for human risk assessment remains a fundamental challenge in drug development. Prior preclinical-clinical concordance studies have been constrained by limited drug coverage, reliance on identical-term matching for adverse events (AEs), a...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2026-04-01
|
| Серія: | Frontiers in Toxicology |
| Предмети: | |
| Онлайн доступ: | https://www.frontiersin.org/articles/10.3389/ftox.2026.1731947/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|